Other Barks & Bites for Friday, August 7: USPTO Increases Fees for Patent Filings and AIA Trials, State AGs Ask HHS to March-In on Remdesivir, CAFC Denies American Axle Rehearing

This week in Other Barks & Bites: the Federal Circuit denies petitions for en banc rehearing in a pair of patent cases regarding Section 101 eligibility and holds that the essentiality of patent claims to a standard is a question of fact for the jury; a letter signed by 34 state attorneys general asks U.S. federal health agencies to exercise march-in rights under Bayh-Dole on Gilead’s remdesivir; the USPTO issues final rules for agency fee adjustments, including a $3,500 increase to IPR petitions; the release of Reels on Instagram helps Mark Zuckerberg become the world’s third-richest person; the Western Washington district court denies an interlocutory appeal on a theory of copyright infringement for Amazon “making available” copyrighted sound recordings; former Google engineer Anthony Levandowski is sentenced to 18 months in prison for trade secret theft; and a Chinese patent owner files a patent suit against Apple’s Siri voice assistant feature seeking $1.43 billion USD in damages.

Full Article Available Here